PCSK9 future questioned after Pfizer withdraw from the race

http://www.pfizer.com/news/press-release/press-release-detail/pfizer_discontinues_global_development_of_bococizumab_its_investigational_pcsk9_inhibitor

Pfizer failed with Torcetrapib and now with a monoclonal antigen.

https://en.wikipedia.org/wiki/Torcetrapib